1. Market Research
  2. > Pharmaceutical
  3. > Drug Discovery and Development Market Trends
  4. > Brain Hemorrhage Global Clinical Trials Review, H1, 2015

Brain Hemorrhage Global Clinical Trials Review, H1, 2015

Summary

GlobalData's clinical trial report, “Brain Hemorrhage Global Clinical Trials Review, H1, 2015" provides data on the Brain Hemorrhage clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Brain Hemorrhage. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Brain Hemorrhage. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table Of Contents

Brain Hemorrhage Global Clinical Trials Review, H1, 2015
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Brain Hemorrhage 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Brain Hemorrhage to Central Nervous System Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Brain Hemorrhage to Central Nervous System Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Unaccomplished Trials of Brain Hemorrhage 25
Subjects Recruited Over a Period of Time 27
Clinical Trials by Sponsor Type 28
Prominent Sponsors 29
Top Companies Participating in Brain Hemorrhage Therapeutics Clinical Trials 30
Prominent Drugs 32
Clinical Trial Profiles 33
Clinical Trial Overview of Top Companies 33
Novo A/S 33
Clinical Trial Overview of Novo A/S 33
Shenzhen Hornetcorn Bio-technology Company, Ltd. 34
Clinical Trial Overview of Shenzhen Hornetcorn Bio-technology Company, Ltd. 34
Pfizer Inc. 35
Clinical Trial Overview of Pfizer Inc. 35
Octapharma AG 36
Clinical Trial Overview of Octapharma AG 36
GlaxoSmithKline plc 37
Clinical Trial Overview of GlaxoSmithKline plc 37
BTG plc 38
Clinical Trial Overview of BTG plc 38
AstraZeneca PLC 39
Clinical Trial Overview of AstraZeneca PLC 39
Arbor Pharmaceuticals, LLC. 40
Clinical Trial Overview of Arbor Pharmaceuticals, LLC. 40
Clinical Trial Overview of Top Institutes / Government 41
The Johns Hopkins University 41
Clinical Trial Overview of The Johns Hopkins University 41
China Medical University Hospital 42
Clinical Trial Overview of China Medical University Hospital 42
Kawasaki Medical School Hospital 43
Clinical Trial Overview of Kawasaki Medical School Hospital 43
McMaster University 44
Clinical Trial Overview of McMaster University 44
Oriental Neurosurgery Evidence-Based-Study Team 45
Clinical Trial Overview of Oriental Neurosurgery Evidence-Based-Study Team 45
Seoul National University Hospital 46
Clinical Trial Overview of Seoul National University Hospital 46
Sunnybrook Health Sciences Centre 47
Clinical Trial Overview of Sunnybrook Health Sciences Centre 47
The George Institute for Global Health 48
Clinical Trial Overview of The George Institute for Global Health 48
Thomas Jefferson University 49
Clinical Trial Overview of Thomas Jefferson University 49
Five Key Clinical Profiles 50
Appendix 92
Abbreviations 92
Definitions 92
Research Methodology 93
Secondary Research 93
About GlobalData 94
Contact Us 94
Disclaimer 94
Source 94

List of Tables
Brain Hemorrhage Therapeutics, Global, Clinical Trials by Region, 2015* 7
Brain Hemorrhage Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8
Brain Hemorrhage Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9
Brain Hemorrhage Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2015* 10
Brain Hemorrhage Therapeutics Clinical Trials, Europe, Top Five Countries, 2015* 11
Brain Hemorrhage Therapeutics Clinical Trials, North America, Top Countries, 2015* 12
Brain Hemorrhage Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2015* 13
Brain Hemorrhage Therapeutics Clinical Trials, Central and South America, Top Countries, 2015* 14
Proportion of Brain Hemorrhage to Central Nervous System Clinical Trials, G7 Countries (%), 2015* 15
Brain Hemorrhage Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16
Brain Hemorrhage Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17
Proportion of Brain Hemorrhage to Central Nervous System Clinical Trials, E7 Countries (%), 2015* 18
Brain Hemorrhage Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 19
Brain Hemorrhage Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 20
Brain Hemorrhage Therapeutics, Global, Clinical Trials by Phase, 2015* 21
Brain Hemorrhage Therapeutics, Global, Clinical Trials In Progress by Phase 2015* 22
Brain Hemorrhage Therapeutics, Global, Clinical Trials by Trial Status, 2015* 23
Brain Hemorrhage Therapeutics Clinical Trials, Global, by End Point Status, 2015* 24
Brain Hemorrhage Therapeutics, Global, Suspended Clinical Trials, 2015* 25
Brain Hemorrhage Therapeutics, Global, Withdrawn Clinical Trials, 2015* 25
Brain Hemorrhage Therapeutics, Global, Terminated Clinical Trials, 2015* 26
Brain Hemorrhage Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 27
Brain Hemorrhage Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015* 28
Brain Hemorrhage Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 29
Brain Hemorrhage Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 31
Brain Hemorrhage Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 32
Brain Hemorrhage Therapeutics Clinical Trials Market, Global, Clinical Trials by Novo A/S, 2015* 33
Brain Hemorrhage Therapeutics Clinical Trials Market, Global, Clinical Trials by Shenzhen Hornetcorn Bio-technology Company, Ltd., 2015* 34
Brain Hemorrhage Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2015* 35
Brain Hemorrhage Therapeutics Clinical Trials Market, Global, Clinical Trials by Octapharma AG, 2015* 36
Brain Hemorrhage Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2015* 37
Brain Hemorrhage Therapeutics Clinical Trials Market, Global, Clinical Trials by BTG plc, 2015* 38
Brain Hemorrhage Therapeutics Clinical Trials Market, Global, Clinical Trials by AstraZeneca PLC, 2015* 39
Brain Hemorrhage Therapeutics Clinical Trials Market, Global, Clinical Trials by Arbor Pharmaceuticals, LLC., 2015* 40
Brain Hemorrhage Therapeutics Clinical Trials Market, Global, Clinical Trials by The Johns Hopkins University, 2015* 41
Brain Hemorrhage Therapeutics Clinical Trials Market, Global, Clinical Trials by China Medical University Hospital, 2015* 42
Brain Hemorrhage Therapeutics Clinical Trials Market, Global, Clinical Trials by Kawasaki Medical School Hospital, 2015* 43
Brain Hemorrhage Therapeutics Clinical Trials Market, Global, Clinical Trials by McMaster University, 2015* 44
Brain Hemorrhage Therapeutics Clinical Trials Market, Global, Clinical Trials by Oriental Neurosurgery Evidence-Based-Study Team, 2015* 45
Brain Hemorrhage Therapeutics Clinical Trials Market, Global, Clinical Trials by Seoul National University Hospital, 2015* 46
Brain Hemorrhage Therapeutics Clinical Trials Market, Global, Clinical Trials by Sunnybrook Health Sciences Centre, 2015* 47
Brain Hemorrhage Therapeutics Clinical Trials Market, Global, Clinical Trials by The George Institute for Global Health, 2015* 48
Brain Hemorrhage Therapeutics Clinical Trials Market, Global, Clinical Trials by Thomas Jefferson University, 2015* 49

List of Figures
Brain Hemorrhage Therapeutics, Global, Clinical Trials by Region (%), 2015* 7
Brain Hemorrhage Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8
Brain Hemorrhage Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9
Brain Hemorrhage Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2015* 10
Brain Hemorrhage Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015* 11
Brain Hemorrhage Therapeutics Clinical Trials, North America, Top Countries (%), 2015* 12
Brain Hemorrhage Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2015* 13
Brain Hemorrhage Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2015* 14
Proportion of Brain Hemorrhage to Central Nervous System Clinical Trials, G7 Countries (%), 2015* 15
Brain Hemorrhage Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16
Brain Hemorrhage Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17
Proportion of Brain Hemorrhage to Central Nervous System Clinical Trials, E7 Countries (%), 2015* 18
Brain Hemorrhage Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 19
Brain Hemorrhage Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 20
Brain Hemorrhage Therapeutics, Global, Clinical Trials by Phase (%), 2015* 21
Brain Hemorrhage Therapeutics, Global, Clinical Trials In Progress by Phase, 2015* 22
Brain Hemorrhage Therapeutics, Global, Clinical Trials by Trial Status, 2015* 23
Brain Hemorrhage Therapeutics Clinical Trials, Global, by End Point Status, 2015* 24
Brain Hemorrhage Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 27
Brain Hemorrhage Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015* 28
Brain Hemorrhage Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 29
Brain Hemorrhage Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 30
Brain Hemorrhage Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 32
GlobalData Methodology 93

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Amrita

+1 718 303 2019

Purchase Reports From Reputable Market Research Publishers
Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

  • $ 5650
  • Industry report
  • August 2016
  • by MarketsandMarkets

The global clinical trial management system (CTMS) market is estimated to grow at a CAGR of 11.5% from 2016 to 2021, to reach USD 920.0 billion by 2021. The adoption of CTMS software is on the rise across ...

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

  • $ 5650
  • Industry report
  • October 2016
  • by MarketsandMarkets

The global CRO services market is estimated to grow at a CAGR of 7.4% from 2016 to 2021, to reach USD 41.86 billion by 2021 from USD 29.29 billion in 2016. Growth in this market is primarily attributed ...

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

  • $ 4157
  • Industry report
  • November 2016
  • by Stratistics MRC

According to Stratistics MRC, the Global Clinical Trial Management System (CTMS) market is expected to grow from $493.58 million in 2015 to reach $1118.58 million by 2022 with a CAGR of 12.4%. Huge research ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.